Health Product InfoWatch: March 2026

Health Canada's March 2026 Health Product InfoWatch details recalls and safety updates for various medications, including Bicillin L-A, Bortezomib, Cefazolin, MAR-Amlodipine, and Seasonique/Seasonale. It also announces new market authorizations with conditions for Voxzogo and product monograph updates for Stivarga.

TGA Issues Infringement Notices for Unlawful Importation of Therapeutic Goods

The TGA has issued infringement notices totalling $23,760 to three health practitioners for allegedly importing unapproved therapeutic goods unlawfully. These goods, including unregistered botulinum toxin and hyaluronic acid, have not been assessed by the TGA and may pose health risks.

TGA Opens Consultation on Sunscreen Regulation Improvements

The Therapeutic Goods Administration (TGA) has opened an 8-week public consultation on proposed improvements to sunscreen regulation in Australia. The consultation seeks feedback on options to enhance SPF testing reliability, adopt new technologies, strengthen laboratory oversight, and improve labelling and quality assurance.

HHS and CMS Announce Healthcare Advisory Committee Members

HHS and CMS have announced the members of the new Healthcare Advisory Committee, a federal advisory body composed of healthcare leaders. The committee will provide non-binding recommendations to improve and modernize U.S. healthcare financing and delivery across Medicare, Medicaid, and other programs.

PCAOB Publishes Inspection Reports for Deloitte, KPMG, and Others

The PCAOB has published three new inspection reports for Deloitte Accountants B.V. (Netherlands), KPMG (Ireland), and Mauldin & Jenkins, LLC. Additionally, an expanded report for R&A CPAs PLLC was made public due to unaddressed quality control issues. These reports are part of the PCAOB's ongoing oversight of public company audits.

PCAOB Meeting to Consider Request for Public Comment on Strategic Priorities

The PCAOB will hold an open meeting on March 31, 2026, to consider issuing a request for public comment on its strategic priorities for 2026-2030. Feedback will inform the development of the PCAOB's strategic plan and standard-setting initiatives.

BCSC Halts Trading in Noveris Health Sciences Inc. Securities

The BC Securities Commission (BCSC) has halted trading in Noveris Health Sciences Inc. securities until April 16, 2026. The order was issued due to unexplained trading volume and price fluctuations, discrepancies between offering documents and financial statements, and misleading promotional articles.

PSR Plans Card Fees, Fraud, and Payments Reform for 2026/27

The UK's Payment Systems Regulator (PSR) has outlined its 2026/27 work programme, focusing on reducing high card fees, enhancing APP fraud protections, and fostering innovation in payments. Key initiatives include implementing remedies for weak competition in card fees and continuing efforts against Authorised Push Payment fraud.

FRC Launches Audit Policy Consultations

The Financial Reporting Council (FRC) has launched two consultations seeking stakeholder feedback on UK audit policy. One focuses on the International Standard for Auditing for Less Complex Entities (ISA for LCE), and the other proposes revisions to ISA (UK) 250 and ISA (UK) 270. The FRC is gathering views to inform its engagement with international standard-setters and refine domestic auditing standards.

Rescinds NHLBI Supplement to NIH Data Management and Sharing Policy

The National Heart, Lung, and Blood Institute (NHLBI) has rescinded its supplement to the NIH Policy for Data Management and Sharing (NOT-HL-23-070). Applicants should now refer to updated guidance (NOT-OD-26-046) for Data Management and Sharing Plan information.